Evidence map›Paper›PMID 32570267›Full record

ArticlePediatric research2021

Idiopathic nephrotic syndrome in children: role of regulatory T cells and gut microbiota.

Shoji Tsuji, Shohei Akagawa, Yuko Akagawa, Tadashi Yamaguchi, Jiro Kino, Sohsaku Yamanouchi, Takahisa Kimata, Masaki Hashiyada, Atsushi Akane, Kazunari Kaneko

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Development of the gut microbiota and dysbiosis in children.Bioscience of microbiota, food and health · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Shoji TsujiDepartment of Pediatrics, Kansai Medical University, Osaka, Japan.
Shohei AkagawaDepartment of Pediatrics, Kansai Medical University, Osaka, Japan.
Yuko AkagawaDepartment of Pediatrics, Kansai Medical University, Osaka, Japan.
Tadashi YamaguchiDepartment of Pediatrics, Kansai Medical University, Osaka, Japan.
Jiro KinoDepartment of Pediatrics, Kansai Medical University, Osaka, Japan.
Sohsaku YamanouchiDepartment of Pediatrics, Kansai Medical University, Osaka, Japan.
Takahisa KimataDepartment of Pediatrics, Kansai Medical University, Osaka, Japan.
Masaki HashiyadaDepartment of Legal Medicine, Kansai Medical University, Osaka, Japan.
Atsushi AkaneDepartment of Legal Medicine, Kansai Medical University, Osaka, Japan.
Kazunari KanekoDepartment of Pediatrics, Kansai Medical University, Osaka, Japan. kanekok@hirakata.kmu.ac.jp.
Kansai Medical University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWe investigated whether an association exists between regulatory T cells (Tregs) during initial presentation in children with idiopathic nephrotic syndrome (INS) and later development of frequently relapsing INS.

methodsBlood samples were obtained at onset and at remission from 25 patients (median age, 4.0 years) with INS; eight did not show relapse after initial response (non-relapsing [NR]), whereas 17 showed frequent relapses (frequently relapsing [FR]). Tregs were measured by flow cytometry; increases were compared between groups. Fecal samples were obtained at onset from 20 patients with INS, as well as from 20 age-matched healthy children. Gut microbiota composition was assessed using 16S ribosomal RNA (rRNA) sequencing (ion PGM).

resultsThe rate of increase in Tregs from onset to remission was significantly lower in the FR group (124.78%) than in the NR group (879.16%; P < 0.001). Additionally, 16S rRNA sequencing of gut microbiota showed that the proportion of butyric acid-producing bacteria was significantly lower in the FR group (7.08%) than in the healthy children (17.45%; P < 0.001).

conclusionsIn children with INS, small increases in Tregs in response to steroid treatment were associated with subsequent increased risk of frequent relapses. In addition, the FR group had a greater degree of dysbiosis at onset. IMPACT: A low rate of Tregs increase is associated with subsequent frequent relapses of INS. The increase in Tregs in response to steroid treatment was small when dysbiosis was present in patients with INS, particularly when the proportion of butyrate-producing bacteria was considerably reduced We presume that improvement of dysbiosis by administration of probiotics and prebiotics may enhance the rate of Tregs' increase, thus preventing frequent relapse.

Indexed as

Gastrointestinal MicrobiomeCase-Control StudiesChildChild, PreschoolFecesFemaleFlow CytometryHumansMaleNephrotic SyndromeProspective StudiesRecurrenceRNA, Ribosomal, 16ST-Lymphocytes, RegulatoryRNA, Ribosomal, 16S

Identifiers

PMID32570267
OpenAlexW3035852992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.